Logo image of KPTI

KARYOPHARM THERAPEUTICS INC (KPTI) Stock Analyst Ratings

NASDAQ:KPTI - Nasdaq - US48576U1060 - Common Stock - Currency: USD

0.5984  -0.01 (-1.9%)

After market: 0.609 +0.01 (+1.77%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to KPTI. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.59. This target is 667.05% above the current price.
KPTI was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about KPTI.
In the previous month the buy percentage consensus was at a similar level.
KPTI was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
KPTI Historical Analyst RatingsKPTI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 5 10 15

Price Target & Forecast

Price Low Median Mean High 0.602.025.104.597.35 - 237.57% 752.27% 667.05% 1,128.28%
KPTI Current Analyst RatingKPTI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-02-20 RBC Capital Reiterate Outperform -> Outperform
2025-02-20 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-10 RBC Capital Reiterate Outperform -> Outperform
2025-01-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-06 Piper Sandler Maintains Overweight -> Overweight
2024-11-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-07 RBC Capital Reiterate Outperform -> Outperform
2024-08-07 Baird Maintains Outperform -> Outperform
2024-08-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-28 HC Wainwright & Co. Maintains Buy -> Buy
2024-06-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-09 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-01 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-03 RBC Capital Maintains Outperform -> Outperform
2023-11-03 Piper Sandler Maintains Overweight -> Overweight
2023-08-07 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-08-03 RBC Capital Maintains Outperform -> Outperform
2023-08-03 Piper Sandler Maintains Overweight -> Overweight
2023-08-03 HC Wainwright & Co. Reiterate Buy -> Buy
2023-07-26 Wedbush Maintains Neutral -> Neutral
2023-07-26 HC Wainwright & Co. Reiterate Buy -> Buy
2023-07-18 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-05 RBC Capital Maintains Outperform
2023-05-05 Baird Maintains Outperform
2023-05-05 HC Wainwright & Co. Maintains Buy
2023-04-19 HC Wainwright & Co. Reiterate Buy
2023-02-22 HC Wainwright & Co. Maintains Buy
2023-02-16 HC Wainwright & Co. Reiterate Buy
2023-01-27 Morgan Stanley Maintains Equal-Weight